Transcript
Megan Bobrowski (0:05)
So it is 6:30am and it has just stopped raining. I am waiting outside a courthouse trying to get into this trial that is happening today.
Ryan Knudsen (0:21)
Yesterday morning, our colleague Megan Bobrowski was in Los Angeles. She was there for a landmark trial and to watch testimony from a very high profile witness.
Megan Bobrowski (0:32)
Meta CEO Mark Zuckerberg is supposed to testify. And Mark Zuckerberg is going to be defending himself and the actions of his company.
Ryan Knudsen (0:44)
Today in court, the key questions hanging over Zuckerberg's testimony, is social media designed to be addictive and is it harmful to teenagers? Last week, the plaintiff's attorney, Mark Lanier, spoke about the case on Fox Business. Well, we slapped a subpoena on Mark Zuckerberg on purpose because we've got documents with his name that he authored that we believe show he put profits over the safety of children. Lanier represents a 20 year old woman who claims that she was harmed by social media use as a child. And we're gonna put him on the stand and I'm gonna grill him on him. Meta, which is the parent company of Facebook and Instagram, said in a statement prior to the trial's start that the plaintiff's lawyers will, quote, try to paint an intentionally misleading picture of Meta with cherry picked quotes and snippets of conversations taken out of context. This trial, which is being heard by a jury, is the first of its kind and the first of thousands of similar cases that are expected to go to court in the coming years. Here's Megan again.
Megan Bobrowski (1:56)
These cases are focused on how Meta designed its apps and whether Meta designed its apps to be addictive to people. That is a new argument that we're seeing. So the outcome could fundamentally change how the company operates. This could be a very big reckoning moment for big tech and social media might not ever look the same after this is said and done.
Ryan Knudsen (2:24)
Welcome to the Journal, our show about money, business and power. I'm Ryan knudsen. It's Thursday, February 19th. Coming up on the show, social media on trial.
Advertisement/Announcer (2:50)
For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremphya offers self injection or intravenous infusion from the start. Tremphya is administered as injections under the skin or infusions through a vein every four weeks followed by injections under the skin every four or eight weeks. If your doctor decides that you can self inject Tremphya, proper training is required. Tremphya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis, serious allergic reactions and increased risk of infections and liver problems may occur. Before treatment, your doctor should check you for infections and tuberculosis. Tell your doctor if you have an infection, flu like symptoms or if you need a vaccine. Explore what's possible. Ask your doctor about tremphya today. Call 1-800-526-7736 to learn more or visit tremphyaradio.com 5am I'm up with a crisp
